Product NDC: | 0280-2030 |
Proprietary Name: | Bayer Migraine Formula |
Non Proprietary Name: | Acetaminophen, Aspirin, and Caffeine |
Active Ingredient(s): | 250; 250; 65 mg/1; mg/1; mg/1 & nbsp; Acetaminophen, Aspirin, and Caffeine |
Administration Route(s): | ORAL |
Dosage Form(s): | TABLET |
Coding System: | National Drug Codes(NDC) |
Product NDC: | 0280-2030 |
Labeler Name: | Bayer HealthCare LLC, Consumer Care |
Product Type: | HUMAN OTC DRUG |
FDA Application Number: | ANDA075794 |
Marketing Category: | ANDA |
Start Marketing Date: | 20120626 |
Package NDC: | 0280-2030-50 |
Package Description: | 1 BOTTLE in 1 CARTON (0280-2030-50) > 50 TABLET in 1 BOTTLE |
NDC Code | 0280-2030-50 |
Proprietary Name | Bayer Migraine Formula |
Package Description | 1 BOTTLE in 1 CARTON (0280-2030-50) > 50 TABLET in 1 BOTTLE |
Product NDC | 0280-2030 |
Product Type Name | HUMAN OTC DRUG |
Non Proprietary Name | Acetaminophen, Aspirin, and Caffeine |
Dosage Form Name | TABLET |
Route Name | ORAL |
Start Marketing Date | 20120626 |
Marketing Category Name | ANDA |
Labeler Name | Bayer HealthCare LLC, Consumer Care |
Substance Name | ACETAMINOPHEN; ASPIRIN; CAFFEINE |
Strength Number | 250; 250; 65 |
Strength Unit | mg/1; mg/1; mg/1 |
Pharmaceutical Classes |